ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, presenting promising improvements across several healthcare and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, additional trusted option for therapeutic use, especial